Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Short Course Oncology Therapy(SCOT). A study of post operative chemotherapy for 12 weeks versus 24 weeks with oxaliplatin/Fluorouracil (5FU) to establish disease free survival outcomes in locally advanced colon cancer

X
Trial Profile

Short Course Oncology Therapy(SCOT). A study of post operative chemotherapy for 12 weeks versus 24 weeks with oxaliplatin/Fluorouracil (5FU) to establish disease free survival outcomes in locally advanced colon cancer

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jun 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Capecitabine (Primary) ; Oxaliplatin (Primary) ; Fluorouracil
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Acronyms SCOT
  • Most Recent Events

    • 08 Jun 2021 Results from 6 randomised trials NCT00749450, NCT00646607, NCT01150045, NCT00958737) in the IDEA database used to compare characteristics, tx adherence, and adverse events presented at the 57th Annual Meeting of the American Society of Clinical Oncology.
    • 13 Jan 2021 Results of the pooled analysis of the high-risk stage II disease individual patient data from the four studies within the IDEA collaboration published in the Journal of Clinical Oncology
    • 14 Dec 2013 Accrual to date is 102% according to United Kingdom Clinical Research Network record.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top